Drug (ID: DG01484) and It's Reported Resistant Information
Name
Amrubicin
Synonyms
Amrubicin; 110267-81-7; UNII-93N13LB4Z2; C25H25NO9; 93N13LB4Z2; (+-)-(7S,9S)-9-Acetyl-9-amino-7-((2-deoxy-beta-D-erythro-pentopyranosyl)oxy)-7,8,9,10-tetrahydro-6,11-dihydroxy-5,12-naphthacenedione; (7S,9S)-9-acetyl-9-amino-7-(((2S,4S,5R)-4,5-dihydroxytetrahydro-2H-pyran-2-yl)oxy)-6,11-dihydroxy-7,8,9,10-tetrahydrotetracene-5,12-dione; Amrubicin [USAN:INN]; amrubicina; amrubicine; amrubicinum; Amrubicin Api; (7S,9S)-9-acetyl-9-amino-7-[(2S,4S,5R)-4,5-dihydroxyoxan-2-yl]oxy-6,11-dihydroxy-8,10-dihydro-7H-tetracene-5,12-dione; (7S,9S)-9-acetyl-9-amino-7-{[(2S,4S,5R)-4,5-dihydroxytetrahydro-2H-pyran-2-yl]oxy}-6,11-dihydroxy-7,8,9,10-tetrahydrotetracene-5,12-dione; Amrubicin (USAN/INN); Amrubicin(SM-5887); SCHEMBL9140; CHEMBL1186894; EX-A161; CHEBI:135779; HY-B0067; ZINC3780800; 3441AH; DB06263; LS41109; AC-31129; D08854; W-60403; Q4748723; W-200813; (1S,3S)-3-acetyl-3-amino-5,12-dihydroxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 2-deoxy-beta-D-erythro-pentopyranoside; 5,12-Naphthacenedione, 9-acetyl-9-amino-7-((2-deoxy-beta-D-erythro-pentopyranosyl)oxy)-7,8,9,10-tetrahydro-6,11-dihydroxy-, (7S,9S)-
    Click to Show/Hide
Indication
In total 1 Indication(s)
Malaria [ICD-11: 1F45]
Phase 3
[1]
Structure
Target . NOUNIPROTAC [1]
Click to Show/Hide the Molecular Information and External Link(s) of This Drug
Formula
3
IsoSMILES
CC(=O)[C@]1(C[C@@H](C2=C(C1)C(=C3C(=C2O)C(=O)C4=CC=CC=C4C3=O)O)O[C@H]5C[C@@H]([C@@H](CO5)O)O)N
InChI
InChI=1S/C25H25NO9/c1-10(27)25(26)7-13-18(16(8-25)35-17-6-14(28)15(29)9-34-17)24(33)20-19(23(13)32)21(30)11-4-2-3-5-12(11)22(20)31/h2-5,14-17,28-29,32-33H,6-9,26H2,1H3/t14-,15+,16-,17-,25-/m0/s1
InChIKey
VJZITPJGSQKZMX-XDPRQOKASA-N
PubChem CID
3035016
ChEBI ID
CHEBI:135779
TTD Drug ID
D03DDR
DrugBank ID
DB06263
Type(s) of Resistant Mechanism of This Drug
  UAPP: Unusual Activation of Pro-survival Pathway
Drug Resistance Data Categorized by Their Corresponding Diseases
ICD-02: Benign/in-situ/malignant neoplasm
Click to Show/Hide the Resistance Disease of This Class
Lung cancer [ICD-11: 2C25]
Click to Show/Hide
Drug Sensitivity Data Categorized by Their Corresponding Mechanisms
       Unusual Activation of Pro-survival Pathway (UAPP) Click to Show/Hide
Key Molecule: Quinone reductase 1 (NQO1) [1]
Molecule Alteration Missense mutation
p.P187S (c.559C>T)
Sensitive Disease Lung adenocarcinoma [ICD-11: 2C25.0]
Experimental Note Revealed Based on the Cell Line Data
In Vitro Model A549 cells Lung Homo sapiens (Human) CVCL_0023
NCI-H69 cells Lung Homo sapiens (Human) CVCL_1579
NCI-H460 cells Lung Homo sapiens (Human) CVCL_0459
NCI-H23 cells Lung Homo sapiens (Human) CVCL_1547
PC-1 cells Pancreas Homo sapiens (Human) CVCL_S978
PC-10 cells Lung Homo sapiens (Human) CVCL_7088
QG56 cells Lung Homo sapiens (Human) CVCL_6943
RERF-LC-MT cells Lung Homo sapiens (Human) CVCL_A473
Sk-LC-6 cells Lung Homo sapiens (Human) CVCL_5474
PC9 cells Lung Homo sapiens (Human) CVCL_B260
SK-LC-2 cells Lung Homo sapiens (Human) CVCL_5468
SK-LC-17 cells Lung Homo sapiens (Human) CVCL_5466
SK-LC-1 cells Lung Homo sapiens (Human) CVCL_5458
SBC3 cells Bone marrow Homo sapiens (Human) CVCL_1678
RERF-LC-OK cells Central nervous system Homo sapiens (Human) CVCL_3154
RERF-LC-MS cells Lung Homo sapiens (Human) CVCL_1655
PC6 cells Adrenal gland Rattus norvegicus (Rat) CVCL_7091
NCI-H417 cells Lung Homo sapiens (Human) CVCL_1602
NCI-H1688 cells Liver Homo sapiens (Human) CVCL_1487
DMS53 cells Lung Homo sapiens (Human) CVCL_1177
ACC-LC-94 cells Lung Homo sapiens (Human) CVCL_7032
ACC-LC-80 cells Lymph node Homo sapiens (Human) CVCL_7028
ACC-LC-73 cells Lung Homo sapiens (Human) CVCL_7026
ACC-LC-67 cells Lymph node Homo sapiens (Human) CVCL_7024
ACC-LC-5 cells Cervical lymph node Homo sapiens (Human) CVCL_7020
ACC-LC-48 cells Pericardial effusion Homo sapiens (Human) CVCL_7018
ACC-LC-314 cells Lung Homo sapiens (Human) CVCL_7011
ACC-LC-174 cells Lung Homo sapiens (Human) CVCL_7007
ACC-LC-172 cells Pericardial effusion Homo sapiens (Human) CVCL_7005
Experiment for
Molecule Alteration
Western blotting analysis
Experiment for
Drug Resistance
CellTiter 96 AQueous One assay
Mechanism Description The missense mutation p.P187S (c.559C>T) in gene NQO1 cause the sensitivity of Amrubicin by unusual activation of pro-survival pathway
References
Ref 1 C609T polymorphism of NAD(P)H quinone oxidoreductase 1 as a predictive biomarker for response to amrubicinJ Thorac Oncol. 2011 Nov;6(11):1826-32. doi: 10.1097/JTO.0b013e318229137d.

If you find any error in data or bug in web service, please kindly report it to Dr. Sun and Dr. Zhang.